Quince Therapeutics, Inc. financial statements
Quince Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 83.98M | EODHD |
| Cash and equivalents | USD 5.81M | EODHD |
| Total debt | USD 18.47M | EODHD |
Quince Therapeutics, Inc. financials on 6ix · Quince Therapeutics, Inc. on 6ix